Safety and Efficacy of Melatonin in Patients With Multiple Progressive Primary Sclerosis

Clinical trial NCT03540485 · TERMINATED

Trial details

NCT number: NCT03540485
Sponsor: Fundación Pública Andaluza para la gestión de la Investigación en Sevilla
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Sclerosis, Multiple Autoimmune Diseases of the Nervous System Nervous System Diseases Autoimmune Diseases

Start date: 2019-11-29
Primary completion: 2026-02-18
Enrollment: 25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.